Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Toxic hydrophobic bile acids are a subset of bile acids characterized by their high hydrophobicity, which directly correlates with their cytotoxic potential. These molecules are derived from cholesterol in the liver and further modified by intestinal bacteria. Examples include Deoxycholic acid (DCA), Chenodeoxycholic acid (CDCA), and Lithocholic acid (LCA). When present in excess or improperly processed/conjugated, they become cytotoxic, especially to hepatocytes, by disrupting cell membranes, inducing endoplasmic reticulum stress, and triggering apoptosis or necrosis. The body mitigates toxicity through sulfation and conjugation with glycine/taurine.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Toxic Hydrophobic Bile Acids.